Antonin Levy

Concurrent irradiation with the anti-programmed cell death ligand-1 immune checkpoint blocker durvalumab: Single centre subset analysis from a phase 1/2 trial.

Stereotactic ablative radiotherapy for early stage non-small cell lung cancer: A critical literature review of predictive factors of relapse.

Candidate immune biomarkers for radioimmunotherapy.

The Current Role of Whole Brain Radiation Therapy in Non-Small Cell Lung Cancer Patients.

Concerns about cardiotoxicity in the HERA trial.

Diversity of brain metastases screening and management in non-small cell lung cancer in Europe: Results of the European Organisation for Research and Treatment of Cancer Lung Cancer Group survey.

Metformin for non-small cell lung cancer patients: Opportunities and pitfalls.

Prophylactic Cranial Irradiation for Limited-Stage Small-Cell Lung Cancer Patients: Secondary Findings From the Prospective Randomized Phase 3 CONVERT Trial.

Plerixafor for the Treatment of WHIM Syndrome.

[Therapeutic options for oligoprogressive non-small cell lung cancer].

Current management of limited-stage SCLC and CONVERT trial impact: Results of the EORTC Lung Cancer Group survey.

Defining oligometastatic non-small cell lung cancer: A simulated multidisciplinary expert opinion.

EORTC Lung Cancer Group survey on the definition of NSCLC synchronous oligometastatic disease.

Innate immune receptor NOD2 mediates LGR5 intestinal stem cell protection against ROS cytotoxicity via mitophagy stimulation.

[Role of immunotherapy in locally advanced non-small cell lung cancer].

Methodological Development of Combination Drug and Radiotherapy in Basic and Clinical Research.

Palliation of dysphagia in metastatic oesogastric cancers: An international multidisciplinary position.

[Radiation-oncology horizon 2030: From microbiota to plasma laser].

Can radiation-recall predict long lasting response to immune checkpoint inhibitors?

Drug-Radiotherapy Combination Trial Developments-Response.

[Radiotherapy for oligometastatic non-small cell lung cancer patients].

[Preoperative versus postoperative radiotherapy in soft tissue sarcomas: State of the art and perspectives].